Hints and tips:
...All assets may perform badly under stagflation, but we’d rather own Pepsi, Johnson & Johnson, Kimberly-Clark, Bristol-Myers et al than sit and watch our cash lose its earnings power....
...Bristol-Myers Squibb, a mammoth US drugmaker on the brink of completing a $90bn merger with Celgene — one of the largest in pharma history — is Starboard’s latest target....
...What really happened at Northern Rock, Royal Bank of Scotland et al? This gives you a clearer idea....
International Edition